Evaluating NALIRIFOX vs Modified Gemcitabine, Nab-Paclitaxel and Cisplatin in Patients With Locally Advanced and Metastatic Pancreatic Adenocarcinoma

Abroad (travel likely)
RecruitingPHASE2

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Conditions

Metastatic Pancreatic Adenocarcinoma · Locally Advanced Pancreatic Adenocarcinoma

Locations
  • Medical University of South Carolina Hollings Cancer Center, Charleston, South Carolina, United States